✦ LIBER ✦

Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: Results from the ASPIRE trial

✍ Scribed by Josef S. Smolen; Désirée M. F. M. Van Der Heijde; E. William St.Clair; Paul Emery; Joan M. Bathon; Edward Keystone; Ravinder N. Maini; Joachim R. Kalden; Michael Schiff; Daniel Baker; Chenglong Han; John Han; Mohan Bala; Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group

Book ID: 111698667
Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 118 KB
Volume: 54
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21678

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ultrasonographic and radiographic result

Ultrasonographic and radiographic results from a two-year controlled trial of immediate or one-year–delayed addition of infliximab to ongoing methotrexate therapy in patients with erosive early rheumatoid arthritis

✍ P. C. Taylor; A. Steuer; J. Gruber; C. McClinton; D. O. Cosgrove; M. J. K. Bloml 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 2 views

Tocilizumab inhibits structural joint da

Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year

✍ Joel M. Kremer; Ricardo Blanco; Marek Brzosko; Ruben Burgos-Vargas; Anne-Marie H 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB 👁 3 views